首页> 外文会议>Societaà Italiana Chirurgia Maxillo-Facciale >Type A Botulinum Toxin in the treatment of bruxism clenching and facial pain: randomized blinded placebo-controlled study
【24h】

Type A Botulinum Toxin in the treatment of bruxism clenching and facial pain: randomized blinded placebo-controlled study

机译:在治疗乳白质咬合和面部疼痛的治疗中键入肉毒杆菌毒素:随机盲目安慰剂对照研究

获取原文

摘要

Tooth clenching and tooth grinding are unvoluntary habits that result in facial pain and in TMJ dysfunctions. Positive therapeutic effects of type-A botulinum toxin (BTX-A) on functional disorders and pain syntoms have been known in other anathomical districts.The purpose of this study is to assess the capacity of BTX-A to reduce the masticatory muscular hyperactivity , the facial pain and to improve mandibular functionality and psychological conditions similar to therapy with bite plane.
机译:牙齿握紧和牙齿研磨是不自愿的习惯,导致面部疼痛和TMJ功能障碍。类型 - 肉毒杆菌毒素(BTX-A)对功能性疾病和疼痛同学的阳性治疗效果在其他卫生区是已知的。本研究的目的是评估BTX-A的能力,以减少咀嚼肌肉多动症,面部疼痛,改善与咬合平面的颌骨功能和心理条件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号